Introduction
Array-comparative genomic hybridization (a-CGH) assay has made the genome-wide screening of genomic copy-number variations (CNVs) possible, enabling to assign genetic diagnoses to phenotypes, which could not be accounted for in the past. [1] MICrocephaly, disproportionate pontine and cerebellar
hypoplasia (MICPCH) syndrome [Online Mendelian
Inheritance in Man (OMIM) number 300749], a rare clinico-radiological phenotype, was first described by Najm et al. and linked to calcium/calmodulin-dependent serine protein kinase (CASK) gene mutations. [2, 3] The core phenotype comprises severe neurodevelopmental delay, microcephaly, and disproportionate pontine and cerebellar hypoplasia. Moog [4] has further defined the phenotypical spectrum of the syndrome.
Neuroradiological features associated with CASK mutations have been refined by Takanashi. [5] To date, forty five or so female patients with characteristic phenotype and two male patients with lethal form have been reported. [2, 4, [6] [7] [8] We report a girl with clinico-radiologic features of MICPCH syndrome, whose conventional cytogenetic analysis was normal and a subsequent a-CGH analysis discovered microduplication in CASK gene at Xp11.4. 
Case Report

Discussion
MICPCH syndrome is a rare X-linked genetic disorder caused by CASK gene mutations and is characterized by neurodevelopmental delay and specific brain malformations. [2, 3] CASK, a multi-domain scaffolding protein, is a member of membrane associated guanylate kinase protein family, [9] which regulates presynaptic neurotransmitter release, postsynaptic ion-channel function, and expression of genes associated with brain development. [10, 11] Evidence suggests that loss-of-function CASK gene mutations lead to X chromosome inactivation, causing severe phenotype, whereas hypomorphic missense CASK mutations produce less severe phenotypes. [4] Deletions and intragenic mutations have been associated with MICPCH syndrome more commonly than duplications. [3, 4] Inversion of the duplicated fragment results in a null allele. [4] Almost invariably, the CASK genetic aberrations are de novo, resulting most commonly from the mutational mechanism of non-allelic recombination. [2] Najm [2] studied four females and one male who died in neonatal period to describe the core phenotype and found CNVs, gene inversion and single nucleotide polymorphism as the possible mutational mechanisms.
Hayashi [7] in his ten cases discovered nonsense mutations,
2-bp deletions, exon-intron junction mutations, interstitial
duplications, and heterozygous deletions with almost equal frequency. Moog [4] reported 20 patients of which 11 showed submicroscopic CNVs, including nine deletions and two duplications in the CASK gene. Recently, Burglen [8] have reported 13 patients (11 females and 2 males) with de novo CASK gene mutations, 10 being intragenic mutations and 3 Xp11.4 deletions.
The core MICPCH syndrome clinical phenotype, originally described by Najm, [2] was further defined by Moog, [4] and confirmed by Burglen. [8] It includes severe neurodevelopmental delay, varying degrees small or short nose, long philtrum, small chin, and/or large ears, hypoplastic toe nails etc. [4] Takanashi [5] described the radiological phenotypic spectrum associated with CASK gene mutations, which confirmed the findings of Najm [2] and was, in turn, corroborated by observations recorded by Moog [4] MRI revealed varying degrees of brainstem and cerebellar hypoplasia and in some cases, showed increase in the fourth ventricle size, subtle changes in gyral pattern in frontal cortex, and mild dilatation of lateral ventricles. [2, 4, 5] Takanashi [5] also concluded that a relatively normal corpus callosum with low cerebrum/ corpus callosum ratio in a girl with microcephaly and neurodevelopmental delay, alludes to the possibility of CASK gene mutation, as the pontocerebeller hypoplasia in non-CASK gene mutations is associated with thinning of corpus callosum.
Our case fits in the phenotypic and genotypic features of MICPCH syndrome described above. Severe neurodevelopmental delay, marked microcephaly, small cerebellum, prominent lateral ventricles, and dysmorphic features such as short nose, long philtrum, prominent maxilla, and large ears fit in the clinico-radiologic phenotype described. [2, 4, 5, 8] Normal appearing corpus callosum (CC) in our patient is in line with observations made by Takanashi. [5] Minimal vermis involvement in our case was reported by Moog [4] in patient 10, 11, and 12. As seen in our case, hypoplastic toe nails were documented in patient 7 by Moog [4] and patient 10 by
Burglen. [8] Fourth ventricle size was near normal in our case as was reported by Moog [4] in five of their patients.
Although, typically cerebellum and vermis are affected equally, our case, like patient 7 of Moog [4] and patients 10, 11 and 12 of Burglen [8] had a subtly affected vermis.
CASK gene duplication, found in our case, has been reported only in a small number of reported MICPCH syndrome cases [3, 4] and therefore, seems to be a less common mutational mechanism to produce MICHPCH syndrome. Despite extensive investigations in our case, the diagnosis remained elusive until a-CGH analysis uncovered micro-duplication, which was earlier reported in two cases by Hayashi [7] and in patients 21 and 25 reported by Moog. [4] Based on the preceding discussion, it can be suggested that in girls presenting with severe neurodevelopmental delay and microcephaly, if neuroimaging depicts ponto-cerebellar hypoplasia with normal CC, a-CGH analysis may be carried out to ascertain genetic diagnosis. [2, 3, 4, 5, 8] 
Conclusion
